nodes	percent_of_prediction	percent_of_DWPC	metapath
Niclosamide—CYP2C9—Medroxyprogesterone Acetate—uterine cancer	0.196	0.367	CbGbCtD
Niclosamide—CYP1A2—Progesterone—uterine cancer	0.144	0.27	CbGbCtD
Niclosamide—CYP2C9—Progesterone—uterine cancer	0.13	0.243	CbGbCtD
Niclosamide—CYP1A2—Etoposide—uterine cancer	0.0644	0.121	CbGbCtD
Niclosamide—STAT3—exocrine gland—uterine cancer	0.0251	0.165	CbGeAlD
Niclosamide—STAT3—myometrium—uterine cancer	0.0139	0.0916	CbGeAlD
Niclosamide—STAT3—epithelium—uterine cancer	0.0109	0.0719	CbGeAlD
Niclosamide—STAT3—uterine cervix—uterine cancer	0.0108	0.0713	CbGeAlD
Niclosamide—STAT3—smooth muscle tissue—uterine cancer	0.0105	0.0693	CbGeAlD
Niclosamide—STAT3—decidua—uterine cancer	0.0103	0.0679	CbGeAlD
Niclosamide—STAT3—renal system—uterine cancer	0.0101	0.0667	CbGeAlD
Niclosamide—STAT3—endometrium—uterine cancer	0.00981	0.0645	CbGeAlD
Niclosamide—STAT3—mammalian vulva—uterine cancer	0.00949	0.0624	CbGeAlD
Niclosamide—STAT3—uterus—uterine cancer	0.00904	0.0594	CbGeAlD
Niclosamide—STAT3—female reproductive system—uterine cancer	0.00812	0.0534	CbGeAlD
Niclosamide—Meclofenamic acid—AKR1C3—uterine cancer	0.00771	1	CrCbGaD
Niclosamide—STAT3—female gonad—uterine cancer	0.00739	0.0486	CbGeAlD
Niclosamide—STAT3—vagina—uterine cancer	0.00735	0.0483	CbGeAlD
Niclosamide—STAT3—lymph node—uterine cancer	0.00475	0.0313	CbGeAlD
Niclosamide—CYP1A2—renal system—uterine cancer	0.0024	0.0158	CbGeAlD
Niclosamide—CYP2C9—female reproductive system—uterine cancer	0.00182	0.012	CbGeAlD
Niclosamide—STAT3—AGE/RAGE pathway—AKT1—uterine cancer	0.000478	0.00156	CbGpPWpGaD
Niclosamide—STAT3—TSH signaling pathway—AKT1—uterine cancer	0.000478	0.00156	CbGpPWpGaD
Niclosamide—STAT3—Downstream signal transduction—ERBB2—uterine cancer	0.000477	0.00155	CbGpPWpGaD
Niclosamide—STAT3—EGF/EGFR Signaling Pathway—ERBB2—uterine cancer	0.000474	0.00155	CbGpPWpGaD
Niclosamide—STAT3—Rac1/Pak1/p38/MMP-2 pathway—AKT1—uterine cancer	0.000472	0.00154	CbGpPWpGaD
Niclosamide—STAT3—Disease—AKR1B10—uterine cancer	0.00046	0.0015	CbGpPWpGaD
Niclosamide—CYP1A2—Tryptophan metabolism—CYP19A1—uterine cancer	0.00046	0.0015	CbGpPWpGaD
Niclosamide—STAT3—BDNF signaling pathway—CTNNB1—uterine cancer	0.000456	0.00149	CbGpPWpGaD
Niclosamide—STAT3—Signaling by SCF-KIT—PTEN—uterine cancer	0.000452	0.00147	CbGpPWpGaD
Niclosamide—CYP2C9—Metapathway biotransformation—AKR1B10—uterine cancer	0.000452	0.00147	CbGpPWpGaD
Niclosamide—STAT3—Cellular Senescence—CDKN2A—uterine cancer	0.000444	0.00145	CbGpPWpGaD
Niclosamide—STAT3—PDGFR-beta signaling pathway—NRAS—uterine cancer	0.000444	0.00145	CbGpPWpGaD
Niclosamide—STAT3—Signaling by FGFR in disease—ERBB2—uterine cancer	0.000442	0.00144	CbGpPWpGaD
Niclosamide—STAT3—Downstream signal transduction—CDKN1B—uterine cancer	0.000441	0.00144	CbGpPWpGaD
Niclosamide—STAT3—ErbB1 downstream signaling—KRAS—uterine cancer	0.000439	0.00143	CbGpPWpGaD
Niclosamide—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	0.000435	0.00142	CbGpPWpGaD
Niclosamide—STAT3—Signaling by PDGF—ERBB2—uterine cancer	0.000432	0.00141	CbGpPWpGaD
Niclosamide—STAT3—Leptin signaling pathway—AKT1—uterine cancer	0.000432	0.00141	CbGpPWpGaD
Niclosamide—STAT3—Signaling by Interleukins—KRAS—uterine cancer	0.00043	0.0014	CbGpPWpGaD
Niclosamide—CYP2C9—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	0.000429	0.0014	CbGpPWpGaD
Niclosamide—CYP2C9—Metapathway biotransformation—AKR1B1—uterine cancer	0.00042	0.00137	CbGpPWpGaD
Niclosamide—CYP1A2—Phase 1 - Functionalization of compounds—CYP11A1—uterine cancer	0.00041	0.00134	CbGpPWpGaD
Niclosamide—STAT3—Signaling by FGFR in disease—CDKN1B—uterine cancer	0.000409	0.00133	CbGpPWpGaD
Niclosamide—STAT3—Downstream signal transduction—PTEN—uterine cancer	0.000406	0.00133	CbGpPWpGaD
Niclosamide—STAT3—EGF/EGFR Signaling Pathway—PTEN—uterine cancer	0.000404	0.00132	CbGpPWpGaD
Niclosamide—STAT3—ErbB1 downstream signaling—PIK3CA—uterine cancer	0.000404	0.00132	CbGpPWpGaD
Niclosamide—STAT3—Signaling by SCF-KIT—NRAS—uterine cancer	0.000403	0.00132	CbGpPWpGaD
Niclosamide—STAT3—Cellular Senescence—CXCL8—uterine cancer	0.000403	0.00131	CbGpPWpGaD
Niclosamide—STAT3—Signaling by PDGF—CDKN1B—uterine cancer	0.0004	0.00131	CbGpPWpGaD
Niclosamide—STAT3—Signaling by Interleukins—PIK3CA—uterine cancer	0.000395	0.00129	CbGpPWpGaD
Niclosamide—STAT3—CXCR4-mediated signaling events—AKT1—uterine cancer	0.000394	0.00129	CbGpPWpGaD
Niclosamide—STAT3—MicroRNAs in cardiomyocyte hypertrophy—AKT1—uterine cancer	0.000394	0.00129	CbGpPWpGaD
Niclosamide—STAT3—Cellular Senescence—CDKN1B—uterine cancer	0.000393	0.00128	CbGpPWpGaD
Niclosamide—STAT3—NGF signalling via TRKA from the plasma membrane—ERBB2—uterine cancer	0.000391	0.00128	CbGpPWpGaD
Niclosamide—CYP1A2—Metapathway biotransformation—AKR1B10—uterine cancer	0.000386	0.00126	CbGpPWpGaD
Niclosamide—STAT3—PDGFR-beta signaling pathway—KRAS—uterine cancer	0.000382	0.00125	CbGpPWpGaD
Niclosamide—STAT3—Disease—RNF43—uterine cancer	0.000381	0.00124	CbGpPWpGaD
Niclosamide—STAT3—Signaling by FGFR in disease—PTEN—uterine cancer	0.000377	0.00123	CbGpPWpGaD
Niclosamide—STAT3—Androgen receptor signaling pathway—AKT1—uterine cancer	0.000376	0.00123	CbGpPWpGaD
Niclosamide—STAT3—ErbB1 downstream signaling—HRAS—uterine cancer	0.000373	0.00122	CbGpPWpGaD
Niclosamide—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	0.000372	0.00121	CbGpPWpGaD
Niclosamide—STAT3—Signaling by PDGF—PTEN—uterine cancer	0.000368	0.0012	CbGpPWpGaD
Niclosamide—CYP1A2—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	0.000367	0.0012	CbGpPWpGaD
Niclosamide—STAT3—Signaling by Interleukins—HRAS—uterine cancer	0.000365	0.00119	CbGpPWpGaD
Niclosamide—STAT3—Downstream signal transduction—NRAS—uterine cancer	0.000363	0.00118	CbGpPWpGaD
Niclosamide—STAT3—NGF signalling via TRKA from the plasma membrane—CDKN1B—uterine cancer	0.000362	0.00118	CbGpPWpGaD
Niclosamide—CYP1A2—Metapathway biotransformation—AKR1B1—uterine cancer	0.000359	0.00117	CbGpPWpGaD
Niclosamide—CYP2C9—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	0.000353	0.00115	CbGpPWpGaD
Niclosamide—STAT3—PDGFR-beta signaling pathway—PIK3CA—uterine cancer	0.000351	0.00115	CbGpPWpGaD
Niclosamide—STAT3—Signaling by SCF-KIT—KRAS—uterine cancer	0.000347	0.00113	CbGpPWpGaD
Niclosamide—STAT3—Signaling by FGFR in disease—NRAS—uterine cancer	0.000336	0.0011	CbGpPWpGaD
Niclosamide—STAT3—Cellular responses to stress—CDKN2A—uterine cancer	0.000336	0.00109	CbGpPWpGaD
Niclosamide—STAT3—NGF signalling via TRKA from the plasma membrane—PTEN—uterine cancer	0.000334	0.00109	CbGpPWpGaD
Niclosamide—STAT3—ErbB1 downstream signaling—AKT1—uterine cancer	0.00033	0.00108	CbGpPWpGaD
Niclosamide—STAT3—Signaling by PDGF—NRAS—uterine cancer	0.000329	0.00107	CbGpPWpGaD
Niclosamide—STAT3—PDGFR-beta signaling pathway—HRAS—uterine cancer	0.000325	0.00106	CbGpPWpGaD
Niclosamide—STAT3—Developmental Biology—SMAD3—uterine cancer	0.000325	0.00106	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—AKR1B10—uterine cancer	0.000322	0.00105	CbGpPWpGaD
Niclosamide—STAT3—Signaling by SCF-KIT—PIK3CA—uterine cancer	0.000319	0.00104	CbGpPWpGaD
Niclosamide—STAT3—Disease—AKR1C1—uterine cancer	0.000314	0.00102	CbGpPWpGaD
Niclosamide—STAT3—Downstream signal transduction—KRAS—uterine cancer	0.000312	0.00102	CbGpPWpGaD
Niclosamide—STAT3—EGF/EGFR Signaling Pathway—KRAS—uterine cancer	0.000311	0.00101	CbGpPWpGaD
Niclosamide—CYP2C9—Metapathway biotransformation—AKR1C1—uterine cancer	0.000308	0.00101	CbGpPWpGaD
Niclosamide—CYP1A2—Aryl Hydrocarbon Receptor—ESR1—uterine cancer	0.000307	0.001	CbGpPWpGaD
Niclosamide—STAT3—Cellular responses to stress—CXCL8—uterine cancer	0.000304	0.000993	CbGpPWpGaD
Niclosamide—CYP1A2—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	0.000301	0.000983	CbGpPWpGaD
Niclosamide—STAT3—Signaling by NGF—ERBB2—uterine cancer	0.000301	0.000982	CbGpPWpGaD
Niclosamide—STAT3—NGF signalling via TRKA from the plasma membrane—NRAS—uterine cancer	0.000298	0.000971	CbGpPWpGaD
Niclosamide—STAT3—Cellular responses to stress—CDKN1B—uterine cancer	0.000297	0.000969	CbGpPWpGaD
Niclosamide—STAT3—Signaling by SCF-KIT—HRAS—uterine cancer	0.000295	0.000962	CbGpPWpGaD
Niclosamide—STAT3—BDNF signaling pathway—HRAS—uterine cancer	0.00029	0.000946	CbGpPWpGaD
Niclosamide—STAT3—Signaling by FGFR in disease—KRAS—uterine cancer	0.000289	0.000944	CbGpPWpGaD
Niclosamide—STAT3—Downstream signal transduction—PIK3CA—uterine cancer	0.000287	0.000935	CbGpPWpGaD
Niclosamide—STAT3—Signaling by PDGF—KRAS—uterine cancer	0.000283	0.000923	CbGpPWpGaD
Niclosamide—STAT3—Signaling by NGF—CDKN1B—uterine cancer	0.000279	0.000909	CbGpPWpGaD
Niclosamide—STAT3—Disease—DCN—uterine cancer	0.000272	0.000886	CbGpPWpGaD
Niclosamide—CYP2C9—Metapathway biotransformation—GPX3—uterine cancer	0.000271	0.000882	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—RNF43—uterine cancer	0.000267	0.000871	CbGpPWpGaD
Niclosamide—STAT3—Developmental Biology—MET—uterine cancer	0.000266	0.000868	CbGpPWpGaD
Niclosamide—STAT3—Signaling by FGFR in disease—PIK3CA—uterine cancer	0.000266	0.000867	CbGpPWpGaD
Niclosamide—STAT3—Downstream signal transduction—HRAS—uterine cancer	0.000265	0.000865	CbGpPWpGaD
Niclosamide—STAT3—EGF/EGFR Signaling Pathway—HRAS—uterine cancer	0.000264	0.000861	CbGpPWpGaD
Niclosamide—CYP1A2—Metapathway biotransformation—AKR1C1—uterine cancer	0.000263	0.000859	CbGpPWpGaD
Niclosamide—STAT3—Cellular responses to stress—EP300—uterine cancer	0.000261	0.000851	CbGpPWpGaD
Niclosamide—STAT3—Signaling by SCF-KIT—AKT1—uterine cancer	0.00026	0.00085	CbGpPWpGaD
Niclosamide—STAT3—Immune System—IRF1—uterine cancer	0.00026	0.00085	CbGpPWpGaD
Niclosamide—STAT3—Signaling by PDGF—PIK3CA—uterine cancer	0.00026	0.000848	CbGpPWpGaD
Niclosamide—STAT3—Signaling by NGF—PTEN—uterine cancer	0.000257	0.000837	CbGpPWpGaD
Niclosamide—STAT3—NGF signalling via TRKA from the plasma membrane—KRAS—uterine cancer	0.000256	0.000836	CbGpPWpGaD
Niclosamide—STAT3—BDNF signaling pathway—AKT1—uterine cancer	0.000256	0.000835	CbGpPWpGaD
Niclosamide—CYP2C9—Biological oxidations—CYP11A1—uterine cancer	0.000255	0.000831	CbGpPWpGaD
Niclosamide—CYP2C9—Metapathway biotransformation—CYP11A1—uterine cancer	0.000251	0.000819	CbGpPWpGaD
Niclosamide—STAT3—Cellular responses to stress—VEGFA—uterine cancer	0.000247	0.000806	CbGpPWpGaD
Niclosamide—STAT3—Cellular Senescence—TP53—uterine cancer	0.000247	0.000806	CbGpPWpGaD
Niclosamide—STAT3—Signaling by FGFR in disease—HRAS—uterine cancer	0.000246	0.000802	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—INHBA—uterine cancer	0.000244	0.000797	CbGpPWpGaD
Niclosamide—STAT3—Disease—AKR1C3—uterine cancer	0.000242	0.000789	CbGpPWpGaD
Niclosamide—STAT3—Signaling by PDGF—HRAS—uterine cancer	0.000241	0.000785	CbGpPWpGaD
Niclosamide—CYP2C9—Metapathway biotransformation—AKR1C3—uterine cancer	0.000237	0.000774	CbGpPWpGaD
Niclosamide—STAT3—Disease—HMGA1—uterine cancer	0.000236	0.000768	CbGpPWpGaD
Niclosamide—STAT3—NGF signalling via TRKA from the plasma membrane—PIK3CA—uterine cancer	0.000235	0.000768	CbGpPWpGaD
Niclosamide—STAT3—Downstream signal transduction—AKT1—uterine cancer	0.000234	0.000764	CbGpPWpGaD
Niclosamide—STAT3—Immune System—FBXW7—uterine cancer	0.000233	0.000761	CbGpPWpGaD
Niclosamide—STAT3—EGF/EGFR Signaling Pathway—AKT1—uterine cancer	0.000233	0.00076	CbGpPWpGaD
Niclosamide—STAT3—Cytokine Signaling in Immune system—NRAS—uterine cancer	0.000233	0.00076	CbGpPWpGaD
Niclosamide—CYP1A2—Metapathway biotransformation—GPX3—uterine cancer	0.000231	0.000754	CbGpPWpGaD
Niclosamide—STAT3—Signaling by NGF—NRAS—uterine cancer	0.000229	0.000747	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	0.000226	0.000737	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—AKR1C1—uterine cancer	0.00022	0.000717	CbGpPWpGaD
Niclosamide—STAT3—NGF signalling via TRKA from the plasma membrane—HRAS—uterine cancer	0.000218	0.000711	CbGpPWpGaD
Niclosamide—CYP1A2—Biological oxidations—CYP11A1—uterine cancer	0.000218	0.00071	CbGpPWpGaD
Niclosamide—STAT3—Signaling by FGFR in disease—AKT1—uterine cancer	0.000217	0.000708	CbGpPWpGaD
Niclosamide—STAT3—Disease—FBXW7—uterine cancer	0.000215	0.000703	CbGpPWpGaD
Niclosamide—CYP1A2—Metapathway biotransformation—CYP11A1—uterine cancer	0.000215	0.0007	CbGpPWpGaD
Niclosamide—STAT3—Signaling by PDGF—AKT1—uterine cancer	0.000212	0.000693	CbGpPWpGaD
Niclosamide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—uterine cancer	0.000209	0.000681	CbGpPWpGaD
Niclosamide—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—uterine cancer	0.000209	0.000681	CbGpPWpGaD
Niclosamide—CYP1A2—Metapathway biotransformation—AKR1C3—uterine cancer	0.000203	0.000661	CbGpPWpGaD
Niclosamide—STAT3—Cytokine Signaling in Immune system—KRAS—uterine cancer	0.0002	0.000654	CbGpPWpGaD
Niclosamide—STAT3—Signaling by NGF—KRAS—uterine cancer	0.000197	0.000643	CbGpPWpGaD
Niclosamide—STAT3—Developmental Biology—ERBB2—uterine cancer	0.000194	0.000634	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	0.000193	0.00063	CbGpPWpGaD
Niclosamide—STAT3—NGF signalling via TRKA from the plasma membrane—AKT1—uterine cancer	0.000192	0.000627	CbGpPWpGaD
Niclosamide—STAT3—Immune System—SOCS3—uterine cancer	0.000191	0.000623	CbGpPWpGaD
Niclosamide—CYP2C9—Biological oxidations—CYP19A1—uterine cancer	0.000187	0.000611	CbGpPWpGaD
Niclosamide—STAT3—Cellular responses to stress—TP53—uterine cancer	0.000187	0.000609	CbGpPWpGaD
Niclosamide—CYP2C9—Metapathway biotransformation—CYP19A1—uterine cancer	0.000185	0.000603	CbGpPWpGaD
Niclosamide—STAT3—Cytokine Signaling in Immune system—PIK3CA—uterine cancer	0.000184	0.000601	CbGpPWpGaD
Niclosamide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—uterine cancer	0.000183	0.000598	CbGpPWpGaD
Niclosamide—CYP1A2—Aryl Hydrocarbon Receptor—EP300—uterine cancer	0.000183	0.000598	CbGpPWpGaD
Niclosamide—STAT3—Signaling by NGF—PIK3CA—uterine cancer	0.000181	0.000591	CbGpPWpGaD
Niclosamide—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—uterine cancer	0.000174	0.000566	CbGpPWpGaD
Niclosamide—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—uterine cancer	0.000172	0.00056	CbGpPWpGaD
Niclosamide—STAT3—Cytokine Signaling in Immune system—HRAS—uterine cancer	0.00017	0.000556	CbGpPWpGaD
Niclosamide—STAT3—Developmental Biology—CTNNB1—uterine cancer	0.00017	0.000555	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—AKR1C3—uterine cancer	0.000169	0.000552	CbGpPWpGaD
Niclosamide—STAT3—Disease—CDKN2B—uterine cancer	0.000169	0.000551	CbGpPWpGaD
Niclosamide—STAT3—Signaling by NGF—HRAS—uterine cancer	0.000168	0.000546	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—PGR—uterine cancer	0.000165	0.000538	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism of lipids and lipoproteins—STAR—uterine cancer	0.000163	0.000533	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	0.000163	0.000533	CbGpPWpGaD
Niclosamide—CYP1A2—Biological oxidations—CYP19A1—uterine cancer	0.00016	0.000522	CbGpPWpGaD
Niclosamide—STAT3—Immune System—FGFR2—uterine cancer	0.000159	0.000519	CbGpPWpGaD
Niclosamide—STAT3—Developmental Biology—EP300—uterine cancer	0.000158	0.000516	CbGpPWpGaD
Niclosamide—CYP1A2—Metapathway biotransformation—CYP19A1—uterine cancer	0.000158	0.000515	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—YWHAE—uterine cancer	0.000157	0.000513	CbGpPWpGaD
Niclosamide—STAT3—Disease—SMAD3—uterine cancer	0.000154	0.000503	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—FBXW7—uterine cancer	0.000151	0.000492	CbGpPWpGaD
Niclosamide—STAT3—Developmental Biology—VEGFA—uterine cancer	0.00015	0.000488	CbGpPWpGaD
Niclosamide—STAT3—Signaling by NGF—AKT1—uterine cancer	0.000148	0.000483	CbGpPWpGaD
Niclosamide—STAT3—Developmental Biology—NRAS—uterine cancer	0.000148	0.000482	CbGpPWpGaD
Niclosamide—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—uterine cancer	0.000148	0.000482	CbGpPWpGaD
Niclosamide—STAT3—Disease—FGFR2—uterine cancer	0.000147	0.00048	CbGpPWpGaD
Niclosamide—STAT3—Disease—MTHFR—uterine cancer	0.000142	0.000462	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	0.00014	0.000456	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism of lipids and lipoproteins—STAR—uterine cancer	0.00014	0.000456	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—STK11—uterine cancer	0.000132	0.00043	CbGpPWpGaD
Niclosamide—STAT3—Developmental Biology—KRAS—uterine cancer	0.000127	0.000415	CbGpPWpGaD
Niclosamide—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—uterine cancer	0.000125	0.000409	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—SOCS3—uterine cancer	0.000123	0.000403	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	0.00012	0.000391	CbGpPWpGaD
Niclosamide—STAT3—Immune System—CDH1—uterine cancer	0.000119	0.000387	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—CDKN2B—uterine cancer	0.000118	0.000386	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—IGF1R—uterine cancer	0.000115	0.000374	CbGpPWpGaD
Niclosamide—STAT3—Developmental Biology—HRAS—uterine cancer	0.000108	0.000353	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—SMAD3—uterine cancer	0.000108	0.000352	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—FGFR2—uterine cancer	0.000103	0.000336	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	0.000103	0.000334	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—SRD5A2—uterine cancer	0.000101	0.000328	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—NDUFB11—uterine cancer	0.000101	0.000328	CbGpPWpGaD
Niclosamide—STAT3—Immune System—ERBB2—uterine cancer	0.0001	0.000326	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	9.78e-05	0.000319	CbGpPWpGaD
Niclosamide—STAT3—Developmental Biology—AKT1—uterine cancer	9.55e-05	0.000312	CbGpPWpGaD
Niclosamide—STAT3—Immune System—CDKN1B—uterine cancer	9.26e-05	0.000302	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	9.24e-05	0.000301	CbGpPWpGaD
Niclosamide—STAT3—Disease—ERBB2—uterine cancer	9.23e-05	0.000301	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—ESR1—uterine cancer	8.81e-05	0.000287	CbGpPWpGaD
Niclosamide—STAT3—Immune System—CTNNB1—uterine cancer	8.75e-05	0.000285	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—NDUFB11—uterine cancer	8.6e-05	0.000281	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—SRD5A2—uterine cancer	8.6e-05	0.000281	CbGpPWpGaD
Niclosamide—STAT3—Disease—CDKN1B—uterine cancer	8.55e-05	0.000279	CbGpPWpGaD
Niclosamide—STAT3—Immune System—PTEN—uterine cancer	8.53e-05	0.000278	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	8.36e-05	0.000273	CbGpPWpGaD
Niclosamide—STAT3—Immune System—EP300—uterine cancer	8.13e-05	0.000265	CbGpPWpGaD
Niclosamide—STAT3—Disease—CTNNB1—uterine cancer	8.08e-05	0.000263	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	7.89e-05	0.000257	CbGpPWpGaD
Niclosamide—STAT3—Disease—PTEN—uterine cancer	7.87e-05	0.000257	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—CCL2—uterine cancer	7.75e-05	0.000253	CbGpPWpGaD
Niclosamide—STAT3—Immune System—NRAS—uterine cancer	7.61e-05	0.000248	CbGpPWpGaD
Niclosamide—STAT3—Disease—EP300—uterine cancer	7.51e-05	0.000245	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—STAR—uterine cancer	7.28e-05	0.000237	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—AKR1B1—uterine cancer	7.28e-05	0.000237	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	7.2e-05	0.000235	CbGpPWpGaD
Niclosamide—STAT3—Disease—NRAS—uterine cancer	7.02e-05	0.000229	CbGpPWpGaD
Niclosamide—STAT3—Immune System—KRAS—uterine cancer	6.55e-05	0.000214	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—ERBB2—uterine cancer	6.47e-05	0.000211	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—AKR1B1—uterine cancer	6.22e-05	0.000203	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—STAR—uterine cancer	6.22e-05	0.000203	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	6.15e-05	0.000201	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—CXCL8—uterine cancer	6.13e-05	0.0002	CbGpPWpGaD
Niclosamide—STAT3—Disease—KRAS—uterine cancer	6.05e-05	0.000197	CbGpPWpGaD
Niclosamide—STAT3—Immune System—PIK3CA—uterine cancer	6.02e-05	0.000196	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—CDKN1B—uterine cancer	5.99e-05	0.000195	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—POLD1—uterine cancer	5.71e-05	0.000186	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—CTNNB1—uterine cancer	5.66e-05	0.000185	CbGpPWpGaD
Niclosamide—STAT3—Immune System—HRAS—uterine cancer	5.57e-05	0.000182	CbGpPWpGaD
Niclosamide—STAT3—Disease—PIK3CA—uterine cancer	5.55e-05	0.000181	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—PTEN—uterine cancer	5.51e-05	0.00018	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—AKR1C1—uterine cancer	5.34e-05	0.000174	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—EP300—uterine cancer	5.26e-05	0.000172	CbGpPWpGaD
Niclosamide—STAT3—Disease—HRAS—uterine cancer	5.14e-05	0.000168	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—VEGFA—uterine cancer	4.98e-05	0.000162	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—NRAS—uterine cancer	4.92e-05	0.00016	CbGpPWpGaD
Niclosamide—STAT3—Immune System—AKT1—uterine cancer	4.91e-05	0.00016	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—POLD1—uterine cancer	4.88e-05	0.000159	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—RRM2—uterine cancer	4.76e-05	0.000155	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—DCN—uterine cancer	4.62e-05	0.000151	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—AKR1C1—uterine cancer	4.57e-05	0.000149	CbGpPWpGaD
Niclosamide—STAT3—Disease—AKT1—uterine cancer	4.54e-05	0.000148	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—CYP11A1—uterine cancer	4.36e-05	0.000142	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—KRAS—uterine cancer	4.23e-05	0.000138	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—AKR1C3—uterine cancer	4.11e-05	0.000134	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—RRM2—uterine cancer	4.07e-05	0.000133	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—DCN—uterine cancer	3.95e-05	0.000129	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—PIK3CA—uterine cancer	3.89e-05	0.000127	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—TP53—uterine cancer	3.76e-05	0.000123	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—CYP11A1—uterine cancer	3.72e-05	0.000121	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—HRAS—uterine cancer	3.6e-05	0.000117	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—AKR1C3—uterine cancer	3.51e-05	0.000115	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—STK11—uterine cancer	3.2e-05	0.000105	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—CYP19A1—uterine cancer	3.2e-05	0.000105	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—AKT1—uterine cancer	3.18e-05	0.000104	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	3.01e-05	9.81e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism of lipids and lipoproteins—EP300—uterine cancer	2.87e-05	9.36e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—STK11—uterine cancer	2.74e-05	8.93e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—CYP19A1—uterine cancer	2.74e-05	8.93e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	2.57e-05	8.38e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism of lipids and lipoproteins—EP300—uterine cancer	2.45e-05	8e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—MTHFR—uterine cancer	2.41e-05	7.85e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	2.12e-05	6.92e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—MTHFR—uterine cancer	2.06e-05	6.71e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	1.81e-05	5.91e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—PTEN—uterine cancer	1.34e-05	4.37e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—EP300—uterine cancer	1.28e-05	4.17e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—PTEN—uterine cancer	1.14e-05	3.73e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—EP300—uterine cancer	1.09e-05	3.56e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—PIK3CA—uterine cancer	9.45e-06	3.08e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—PIK3CA—uterine cancer	8.08e-06	2.63e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—AKT1—uterine cancer	7.72e-06	2.52e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—AKT1—uterine cancer	6.6e-06	2.15e-05	CbGpPWpGaD
